Published in Appl Environ Microbiol on September 01, 2000
Peptide signaling in the staphylococci. Chem Rev (2010) 1.89
Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother (2007) 1.84
Influence of the two-component system SaeRS on global gene expression in two different Staphylococcus aureus strains. J Bacteriol (2006) 1.76
Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore. Protein Sci (2002) 1.73
Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One (2010) 1.64
The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol Mol Biol Rev (2014) 1.32
The Staphylococcus aureus KdpDE two-component system couples extracellular K+ sensing and Agr signaling to infection programming. Infect Immun (2011) 1.18
Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus. Antimicrob Agents Chemother (2011) 1.12
Allele-dependent differences in quorum-sensing dynamics result in variant expression of virulence genes in Staphylococcus aureus. J Bacteriol (2012) 0.98
CodY deletion enhances in vivo virulence of community-associated methicillin-resistant Staphylococcus aureus clone USA300. Infect Immun (2012) 0.92
Heterogeneity of methicillin-resistant Staphylococcus aureus strains at a German university hospital during a 1-year period. Eur J Clin Microbiol Infect Dis (2005) 0.91
Do differences in Panton-Valentine leukocidin production among international methicillin-resistant Staphylococcus aureus clones affect disease presentation and severity? J Clin Microbiol (2012) 0.87
Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins. Proc Natl Acad Sci U S A (2011) 0.86
Identification of a hydrophobic cleft in the LytTR domain of AgrA as a locus for small molecule interactions that inhibit DNA binding. Biochemistry (2012) 0.85
Staphylococcal Panton-Valentine leucocidin as a major virulence factor associated to furuncles. PLoS One (2011) 0.84
Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors. Antimicrob Agents Chemother (2003) 0.83
Changes in the agr locus affect enteritis caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2009) 0.82
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis (1999) 19.52
Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci U S A (1989) 15.69
Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci U S A (1990) 10.01
Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci U S A (1992) 6.95
A method to isolate RNA from gram-positive bacteria and mycobacteria. Anal Biochem (1994) 4.24
Deletion of the alternative sigma factor sigmaB in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J Bacteriol (1998) 4.18
Sigma-B, a putative operon encoding alternate sigma factor of Staphylococcus aureus RNA polymerase: molecular cloning and DNA sequencing. J Bacteriol (1996) 3.58
Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur J Biochem (1992) 3.54
The molecular architecture of the sar locus in Staphylococcus aureus. J Bacteriol (1996) 3.46
Messenger RNA stability and its role in control of gene expression in bacteria and phages. Annu Rev Genet (1999) 3.17
Molecular interactions between two global regulators, sar and agr, in Staphylococcus aureus. J Biol Chem (1998) 3.09
Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun (1995) 3.08
Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J Bacteriol (1998) 3.01
Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques (1995) 2.90
Transcriptional control of the agr-dependent virulence gene regulator, RNAIII, in Staphylococcus aureus. Mol Microbiol (1996) 2.69
The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants. Mol Microbiol (1990) 2.63
Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro. Infect Immun (2000) 2.50
Hyperproduction of alpha-hemolysin in a sigB mutant is associated with elevated SarA expression in Staphylococcus aureus. Infect Immun (1999) 2.35
Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol (1995) 2.25
Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem (1997) 2.25
Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett (1998) 1.81
Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother (1998) 1.70
Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. Infect Immun (1997) 1.61
Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis. J Clin Microbiol (1999) 1.53
The gamma-hemolysin locus of Staphylococcus aureus comprises three linked genes, two of which are identical to the genes for the F and S components of leukocidin. Infect Immun (1993) 1.31
Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. J Clin Microbiol (1999) 1.26
Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol (1994) 1.22
Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model. J Med Microbiol (1997) 1.11
The staphylococcal pore-forming leukotoxins open Ca2+ channels in the membrane of human polymorphonuclear neutrophils. J Membr Biol (1998) 1.11
Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons. Infection (1998) 0.86
Quantification of human interleukin 18 mRNA expression by competitive reverse transcriptase polymerase chain reaction. Cytokine (1999) 0.86
Quantification of cytokine transcripts using polymerase chain reaction. Eur Cytokine Netw (1997) 0.82
An experimental vaccine that targets staphylococcal virulence. Trends Microbiol (1998) 0.80
Random amplified polymorphic DNA assay is less discriminant than pulsed-field gel electrophoresis for typing strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1993) 3.21
Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun (1995) 3.08
Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry (2001) 2.67
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis (1989) 2.25
Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol (1995) 2.25
Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology (1992) 2.13
High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol (2009) 2.13
Prevalence of Bartonella henselae and Bartonella clarridgeiae in stray cats. J Clin Microbiol (1997) 2.11
Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources. Eur J Clin Microbiol Infect Dis (1996) 2.07
Detection of Legionella spp. in bronchoalveolar lavage fluids by DNA amplification. J Clin Microbiol (1992) 2.03
Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med (1996) 1.98
Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis (1995) 1.97
Bartonella tribocorum sp. nov., a new Bartonella species isolated from the blood of wild rats. Int J Syst Bacteriol (1998) 1.97
Phylogeny of the genus Corynebacterium deduced from analyses of small-subunit ribosomal DNA sequences. Int J Syst Bacteriol (1995) 1.90
Bartonella alsatica sp. nov., a new Bartonella species isolated from the blood of wild rabbits. Int J Syst Bacteriol (1999) 1.87
Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett (1998) 1.81
Nocardia pseudobrasiliensis sp. nov., a new species of Nocardia which groups bacterial strains previously identified as Nocardia brasiliensis and associated with invasive diseases. Int J Syst Bacteriol (1996) 1.74
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry identifies 90% of bacteria directly from blood culture vials. Clin Microbiol Infect (2010) 1.73
Leukocidal toxins of staphylococci. Zentralbl Bakteriol (1999) 1.68
Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease. Am J Med (1998) 1.66
Genomic diversity and phylogenetic relationships among lipid-requiring diphtheroids from humans and characterization of Corynebacterium macginleyi sp. nov. Int J Syst Bacteriol (1995) 1.65
Genomic diversity among Corynebacterium jeikeium strains and comparison with biochemical characteristics and antimicrobial susceptibilities. J Clin Microbiol (1994) 1.64
High-performance liquid chromatography of antibiotics. J Chromatogr (1990) 1.52
Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains. Res Microbiol (1991) 1.48
The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins. Structure (1999) 1.45
Psychometric discrimination between anxiety and depression. J Nerv Ment Dis (1993) 1.40
Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. Microb Pathog (1998) 1.40
Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus. FEBS Lett (2003) 1.37
Taxonomy of Corynebacterium diphtheriae and related taxa, with recognition of Corynebacterium ulcerans sp. nov. nom. rev. FEMS Microbiol Lett (1995) 1.36
The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution. Structure (1997) 1.34
Flow cytometric determination of Panton-Valentine leucocidin S component binding. Infect Immun (2001) 1.34
Characterisation of a synergohymenotropic toxin produced by Staphylococcus intermedius. FEBS Lett (1995) 1.34
Bacteremia due to Gordona sputi in an immunocompromised patient. J Clin Microbiol (1996) 1.34
Leukotriene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutrophils. Infect Immun (1994) 1.32
The interaction of Staphylococcus aureus bi-component gamma-hemolysins and leucocidins with cells and lipid membranes. Biochim Biophys Acta (1998) 1.31
A new purification procedure for Clostridium difficile enterotoxin. Biochem Biophys Res Commun (1984) 1.27
Bartonella birtlesii sp. nov., isolated from small mammals (Apodemus spp.). Int J Syst Evol Microbiol (2000) 1.27
Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. J Clin Microbiol (1999) 1.26
Corynebacterium argentoratense sp. nov., from the human throat. Int J Syst Bacteriol (1995) 1.26
Taxonomic study of Corynebacterium Group ANF-1 strains: Proposal of Corynebacterium afermentans sp. nov. containing the subspecies C. afermentans subsp. afermentans subsp. nov. and C. afermentans subsp. lipophilum subsp. nov. Int J Syst Bacteriol (1993) 1.26
Frequency of isolation of Staphylococcus intermedius from humans. J Clin Microbiol (1997) 1.26
Mode of action of beta-barrel pore-forming toxins of the staphylococcal alpha-hemolysin family. Toxicon (2001) 1.25
O and H serotyping of Pseudomonas cepacia. J Clin Microbiol (1983) 1.24
Peripartum bacteremias due to Leptotrichia amnionii and Sneathia sanguinegens, rare causes of fever during and after delivery. J Clin Microbiol (2004) 1.24
Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol (1994) 1.22
Hospital routine analysis of penicillins, third-generation cephalosporins and aztreonam by conventional and high-speed high-performance liquid chromatography. J Chromatogr (1987) 1.17
[Phenotype characteristics of 100 strains of Pseudomonas cepacia. Proposition of a biovars classification (author's transl)]. Ann Biol Clin (Paris) (1981) 1.15
Application of flow cytometry in toxinology: pathophysiology of human polymorphonuclear leukocytes damaged by a pore-forming toxin from Staphylococcus aureus. Cytometry (1995) 1.12
Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model. J Med Microbiol (1997) 1.11
Corynebacterium seminale sp. nov., a new species associated with genital infections in male patients. J Clin Microbiol (1995) 1.11
The staphylococcal pore-forming leukotoxins open Ca2+ channels in the membrane of human polymorphonuclear neutrophils. J Membr Biol (1998) 1.11
Discoupling the Ca(2+)-activation from the pore-forming function of the bi-component Panton-Valentine leucocidin in human PMNs. FEBS Lett (1999) 1.11
Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases. J Clin Microbiol (2001) 1.07
Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis. J Clin Microbiol (2000) 1.07
A new case of Wolbachia dependence in the genus Asobara: evidence for parthenogenesis induction in Asobara japonica. Heredity (Edinb) (2009) 1.05
Breast milk transmission of a Panton-Valentine leukocidin-producing Staphylococcus aureus strain causing infantile pneumonia. J Clin Microbiol (2001) 1.04
Identification of Mycobacterium shimoidei in a tuberculosis-like cavity by 16S ribosomal DNA direct sequencing. Eur J Clin Microbiol Infect Dis (1996) 1.04
Evaluation of the applicability of amplified rDNA-restriction analysis (ARDRA) to identification of species of the genus Corynebacterium. Res Microbiol (1995) 1.03
Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans. Antimicrob Agents Chemother (1985) 1.03
HPLC quantitation of the six main components of teicoplanin in biological fluids. J Antimicrob Chemother (1988) 1.02
Assessment of biliary excretion of piperacillin-tazobactam in humans. Antimicrob Agents Chemother (1997) 1.02
Corynebacterium singulare sp. nov., a new species for urease-positive strains related to Corynebacterium minutissimum. Int J Syst Bacteriol (1997) 1.02
Comparative study of immunological properties and cytotoxic effects of Clostridium difficile toxin B and Clostridium sordellii toxin L. Toxicon (1992) 1.01
Campylobacter lari bacteremia. Clin Microbiol Infect (2001) 1.01
Enzyme-linked immunosorbent assays for Staphylococcus aureus exfoliative toxins A and B and some applications. J Clin Microbiol (1984) 1.00
[Isolation, identification and clinical significance of species of the Flavobacterium genus]. Ann Biol Clin (Paris) (1983) 1.00
Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies. Diabetes Metab (2009) 0.99
Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum (1996) 0.99
Simultaneous assay for amatoxins and phallotoxins in Amanita phalloides Fr. by high-performance liquid chromatography. J Chromatogr (1992) 0.98
Corynebacterium durum sp. nov., from human clinical specimens. Int J Syst Bacteriol (1997) 0.98
[Exfoliatin in neonatal staphylococcal infections]. Nouv Presse Med (1982) 0.97
Determination of vancomycin in human serum by high-pressure liquid chromatography. Antimicrob Agents Chemother (1985) 0.97
Effect of purified staphylococcal leukocidal toxins on isolated blood polymorphonuclear leukocytes and peritoneal macrophages in vitro. Zentralbl Bakteriol (1998) 0.96
Detection of Borrelia burgdorferi in cerebrospinal fluid of patients with Lyme borreliosis. N Engl J Med (1991) 0.96
Diagnostic value of the indirect immunofluorescence assay in cat scratch disease with Bartonella henselae and Afipia felis antigens. Clin Diagn Lab Immunol (1996) 0.95
[Demonstration by electrosyneresis of 2 exfoliation serotypes produced by Staphylococcus aureus]. Ann Microbiol (Paris) (1983) 0.95
Antibiotic-impregnated plaster of Paris beads. Trials with teicoplanin. Clin Orthop Relat Res (1992) 0.94
Composition of staphylococcal bi-component toxins determines pathophysiological reactions. J Med Microbiol (1997) 0.93
Effect of the cytotoxin of Clostridium difficile on cultured hepatoma cells. Biol Cell (1985) 0.92
Pharmacokinetics of intravenous fusidic acid in patients with cholestasis. Antimicrob Agents Chemother (1993) 0.92
High-performance liquid chromatographic assay for cefepime in serum. J Chromatogr B Biomed Sci Appl (1997) 0.92
The influence of membrane lipids in Staphylococcus aureus gamma-hemolysins pore formation. J Membr Biol (2008) 0.92
[Incidence of meticillin-resistant Staphylococcus aureus in neonatal care unit of departmental hospital centre of Zou Collines in Benin]. Arch Pediatr (2006) 0.91
Retrieving biological activity from LukF-PV mutants combined with different S components implies compatibility between the stem domains of these staphylococcal bicomponent leucotoxins. Infect Immun (2002) 0.91
Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia. J Infect (2004) 0.91